How important is acute cellular rejection? (Q42271082)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on November 2013

Language	Label	Description	Also known as
English	How important is acute cellular rejection?	scientific article published on November 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

How important is acute cellular rejection? (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

author name string

Michael R Charlton

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

publication date

1 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Liver Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

19 Suppl 2

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

S9-13

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'ReSpECT' study.

1 reference

https://api.crossref.org/works/10.1002%2FLT.23743

21 January 2018

Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FLT.23743

21 January 2018

Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome.

1 reference

https://api.crossref.org/works/10.1002%2FLT.23743

21 January 2018

A longitudinal analysis of hepatitis C virus replication following liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.23743

21 January 2018

Effects of corticosteroids on HCV infection

1 reference

https://api.crossref.org/works/10.1002%2FLT.23743

21 January 2018

A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FLT.23743

21 January 2018

12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus

1 reference

https://api.crossref.org/works/10.1002%2FLT.23743

21 January 2018

Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1002%2FLT.23743

21 January 2018

Impact of sirolimus and tacrolimus on mortality and graft loss in liver transplant recipients with or without hepatitis C virus: an analysis of the Scientific Registry of Transplant Recipients Database

1 reference

https://api.crossref.org/works/10.1002%2FLT.23743

21 January 2018

Cyclosporine versus Tacrolimus Treated Liver Transplant Recipients with Chronic Hepatitis C: Outcomes Analysis of the UNOS/OPTN Database

1 reference

https://api.crossref.org/works/10.1002%2FLT.23743

21 January 2018

Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FLT.23743

21 January 2018

Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FLT.23743

21 January 2018

Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.

1 reference

https://api.crossref.org/works/10.1002%2FLT.23743

21 January 2018

Arylsulfatase of human tissue. Studies on a form of arylsulfatase B found predominantly in brain

1 reference

https://api.crossref.org/works/10.1002%2FLT.23743

21 January 2018

Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study

1 reference

https://api.crossref.org/works/10.1002%2FLT.23743

21 January 2018

Mechanisms involved in the side effects of glucocorticoids

1 reference

https://api.crossref.org/works/10.1002%2FLT.23743

21 January 2018

Calcineurin inhibitors acutely improve insulin sensitivity without affecting insulin secretion in healthy human volunteers

1 reference

https://api.crossref.org/works/10.1002%2FLT.23743

21 January 2018

A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance

1 reference

https://api.crossref.org/works/10.1002%2FLT.23743

21 January 2018

Identifiers

10.1002/LT.23743

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42271082&oldid=1568760217"